LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Atalanta Therapeutics

Similar companies to Atalanta Therapeutics

Atalanta Therapeutics Tech Stack

Atalanta Therapeutics uses 8 technology products and services including WordPress, MongoDB, Slick, and more. Explore Atalanta Therapeutics's tech stack below.

  • WordPress
    Content Management System
  • MongoDB
    Database
  • Slick
    Javascript Libraries
  • OWL Carousel
    Javascript Libraries
  • WP Engine
    Platform As A Service
  • Yoast SEO
    Search Engines
  • Bitbucket
    Source Code Management
  • Zoom
    Web Conferencing

Media & News

Atalanta Therapeutics's Email Address Formats

Atalanta Therapeutics uses at least 1 format(s):
Atalanta Therapeutics Email FormatsExamplePercentage
FLast@atalantatx.comJDoe@atalantatx.com
97%
First@atalantatx.comJohn@atalantatx.com
2%
LastF@atalantatx.comDoeJ@atalantatx.com
1%

Frequently Asked Questions

Where is Atalanta Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Atalanta Therapeutics's main headquarters is located at 51 Sleeper Street Boston, MA 02210 US. The company has employees across 2 continents, including North AmericaAsia.

What is Atalanta Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Atalanta Therapeutics's official website is atalantatx.com and has social profiles on LinkedIn.

How much revenue does Atalanta Therapeutics generate?

Minus sign iconPlus sign icon
As of August 2024, Atalanta Therapeutics's annual revenue reached $15M.

What is Atalanta Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Atalanta Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Atalanta Therapeutics have currently?

Minus sign iconPlus sign icon
As of August 2024, Atalanta Therapeutics has approximately 75 employees across 2 continents, including North AmericaAsia. Key team members include Chief Scientific Officer: A. J.Chief Corporate Development Officer: M. M.Vice President In Vitro Biology: G. Y.. Explore Atalanta Therapeutics's employee directory with LeadIQ.

What industry does Atalanta Therapeutics belong to?

Minus sign iconPlus sign icon
Atalanta Therapeutics operates in the Biotechnology Research industry.

What technology does Atalanta Therapeutics use?

Minus sign iconPlus sign icon
Atalanta Therapeutics's tech stack includes WordPressMongoDBSlickOWL CarouselWP EngineYoast SEOBitbucketZoom.

What is Atalanta Therapeutics's email format?

Minus sign iconPlus sign icon
Atalanta Therapeutics's email format typically follows the pattern of . Find more Atalanta Therapeutics email formats with LeadIQ.

How much funding has Atalanta Therapeutics raised to date?

Minus sign iconPlus sign icon
As of August 2024, Atalanta Therapeutics has raised $110M in funding. The last funding round occurred on Jan 11, 2021 for $110M.
Atalanta Therapeutics

Atalanta Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

We are a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing our proprietary RNA interference platform. We were founded by Anastasia Khvorova, Ph.D., Craig Mello, Ph.D., and Neil Aronin, M.D., of the RNA Therapeutics Institute at the University of Massachusetts Medical School, with a Series A funding exclusively by F-Prime Capital. We are headquartered in Boston, Mass. 

Section iconCompany Overview

Headquarters
51 Sleeper Street Boston, MA 02210 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $110M

    Atalanta Therapeutics has raised a total of $110M of funding over 1 rounds. Their latest funding round was raised on Jan 11, 2021 in the amount of $110M.

  • $10M$50M

    Atalanta Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $110M

    Atalanta Therapeutics has raised a total of $110M of funding over 1 rounds. Their latest funding round was raised on Jan 11, 2021 in the amount of $110M.

  • $10M$50M

    Atalanta Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.